Insider Stock Trading History of Fletcher Mark


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fletcher Mark since year 2005. The trader's CIK number is 1229529. At the time of this reporting, Fletcher Mark is the President & CEO of Generex Biotechnology Corp . (stock ticker symbol GNBT). See this page for all insider trading activities at Generex Biotechnology Corp .


Stock purchases, sales, and option exercises reported by insider Fletcher Mark since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-02-09 GNBT Generex Biotechnology Corp Option Ex 14,890,033 .00 14,890
2014-10-06 GNBT Generex Biotechnology Corp Option Ex 470,726 .00 470
2011-04-06 GNBT Generex Biotechnology Corp Buy 20,000 .24 4,780
2009-11-13 GNBT Generex Biotechnology Corp Buy 10,000 .49 4,900
2009-01-12 GNBT Generex Biotechnology Corp Buy 12,359 .32 4,016
2008-10-31 GNBT Generex Biotechnology Corp Buy 25,000 .38 9,375
2008-04-18 GNBT Generex Biotechnology Corp Option Ex 250,000 .89 222,500
2008-04-18 GNBT Generex Biotechnology Corp Sale 228,342 1.15 262,593

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fletcher Mark (President & CEO of Generex Biotechnology Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.